Chemoinformaics analysis of Isofraxidin-7-O-Alpha-L-Glucoside
Molecular Weight | 384.337 | nRot | 5 |
Heavy Atom Molecular Weight | 364.177 | nRig | 18 |
Exact Molecular Weight | 384.106 | nRing | 3 |
Solubility: LogS | -2.107 | nHRing | 2 |
Solubility: LogP | -0.575 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
No. of Oxygen atom | 10 | No. of Arom Bond | 11 |
nHA | 10 | APOL | 49.7459 |
nHD | 4 | BPOL | 29.6121 |
QED | 0.473 |
Synth | 3.801 |
Natural Product Likeliness | 1.872 |
NR-PPAR-gamma | 0.022 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.606 |
HIA | 0.615 |
CACO-2 | -5.643 |
MDCK | 0.0000647 |
BBB | 0.731 |
PPB | 0.376668 |
VDSS | 0.837 |
FU | 0.401308 |
CYP1A2-inh | 0.028 |
CYP1A2-sub | 0.726 |
CYP2c19-inh | 0.011 |
CYP2c19-sub | 0.716 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.371 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.274 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.037 |
CL | 3.371 |
T12 | 0.532 |
hERG | 0.045 |
Ames | 0.285 |
ROA | 0.211 |
SkinSen | 0.034 |
Carcinogencity | 0.53 |
EI | 0.007 |
Respiratory | 0.016 |
NR-Aromatase | 0.615 |
Antiviral | Yes |
Prediction | 0.613776 |